Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Stamps Recall Of Teleflex Percutaneous Thrombolytic Device As Class I

Executive Summary

The US FDA has designated a September recall by Teleflex of its Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thrombolytic Device: 7FR as high-risk class I.

You may also be interested in...



Senators Ask FTC To Investigate COVID-19 Test Price-Gouging

Democrats Markey and Blumenthal say pandemic not only has led to supply shortages but to “predatory and profiteering behavior,” including sales of fraudulent kits or exorbitant prices for approved devices.

Pig Heart Xenotransplant Signals Future Solution To Donor Shortage

US surgeons have given new tailwind to xenotransplantation after successfully implanting a pig’s heart in a human. The breakthrough not only gives hope to the hundreds of patients who die annually for lack of a doner organ, but also to health care R&D departments who see the therapeutic value of transplanted tissues in tackling neurodegenerative disorders and diabetes.

Lawmakers Ask FTC To Investigate Price Gouging Of COVID-19 Tests

US Sens. Ed Markey and Sidney Blumenthal are requesting the Federal Trade Commission to use its power to prevent bad actors from taking advantage of the pandemic.

Topics

UsernamePublicRestriction

Register

MT144791

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel